ProCE Banner Activity

NSABP B-42 10-Yr Follow-up: Extended Adjuvant Letrozole After Previous Adjuvant AI Therapy in Postmenopausal Women With HR+ Breast Cancer

Slideset Download
Conference Coverage
In patients with HR+ early breast cancer, use of extended adjuvant letrozole after previous adjuvant AI therapy significantly improved disease-free survival with longer-term follow-up.

Released: December 19, 2019

Expiration: December 17, 2020

No longer available for credit.

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Daiichi Sankyo, Inc.

Genentech TEXT Only

Merck Sharp & Dohme Corp.

Puma Biotechnology, Inc.

Seagen